KR20000051921A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions Download PDF

Info

Publication number
KR20000051921A
KR20000051921A KR1019990002629A KR19990002629A KR20000051921A KR 20000051921 A KR20000051921 A KR 20000051921A KR 1019990002629 A KR1019990002629 A KR 1019990002629A KR 19990002629 A KR19990002629 A KR 19990002629A KR 20000051921 A KR20000051921 A KR 20000051921A
Authority
KR
South Korea
Prior art keywords
extract
stems
mistletoe
leaves
coloratum
Prior art date
Application number
KR1019990002629A
Other languages
Korean (ko)
Inventor
최광훈
Original Assignee
최광훈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최광훈 filed Critical 최광훈
Priority to KR1019990002629A priority Critical patent/KR20000051921A/en
Publication of KR20000051921A publication Critical patent/KR20000051921A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/0261Solvent extraction of solids comprising vibrating mechanisms, e.g. mechanical, acoustical
    • B01D11/0265Applying ultrasound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Acoustics & Sound (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: A pharmaceutical composition and a preparation method thereof are provided to inhibit cholesterol and neutral fat from a deposit on a blood vessel and to prevent and treat hypertension by using Korean mistletoe. CONSTITUTION: A pharmaceutical composition comprises a therapeutically effective amount i.e., 0.01-50 wt% of an extract of Korean mistletoe's leaves, stems or roots. The preparation method comprises: defatting the sample using nonpolar solvents to extract from the Korean mistletoe; vacuum concentrating the extracts obtained using water-soluble organic solvent; extracting with low polar organic solvent which dissolves the concentrate in water.

Description

약학조성물{PHARMACEUTICAL COMPOSITIONS}Pharmaceutical composition {PHARMACEUTICAL COMPOSITIONS}

본 발명은 한국산 겨우살이(Korean mistletoe, Viscum album var.coloratum)의 잎, 줄기 또는 열매로부터 추출한 추출물이 유효성분으로 함유되어 있는 약학조성물과 그 제조방법에 관한 것으로서, 더욱 상세하게는 콜레스테롤 및 중성지방이 혈관내에 침착하는 것을 억제하고 혈압 강하에 탁윌한 효과를 나타내는 약학조성물과 그 제조방법에 관한 것이다.The present invention relates to a pharmaceutical composition containing an extract extracted from the leaves, stems or berries of Korean mistletoe (Viscum album var.coloratum) as an active ingredient, and to a method for preparing the same. The present invention relates to a pharmaceutical composition which inhibits deposition in blood vessels and exhibits an excellent effect on lowering blood pressure, and a method of manufacturing the same.

오늘날 경제의 풍요로움으로 인하여 식생활의 변화에 따른 다량의 동물성지방 섭취와 지질대사의 이상으로 과량의 콜레스테롤 및 중성지방이 혈관에 침착하여 혈관내강을 좁힘으로서 순환계질환과 관련된 여러 종류의 병변을 일으킨다.Due to the richness of today's economy, excessive cholesterol and triglycerides are deposited in blood vessels due to the intake of large amounts of animal fat and lipid metabolism due to changes in diet, and narrowing the lumen of the vessels, causing various types of lesions related to circulatory diseases.

이러한 콜레스테롤과 중성지방에 의한 병변은 전신에서 일어날 수 있으며 뇌혈전, 뇌동맥경화증, 뇌출혈, 협심증, 심근경색, 신경화증 및 고혈압증의 원인이 된다. 이러한 병변을 예방하고 치료하기 위해서는 고지방 및 저 섬유소를 특징으로 하는 동물성위주의 식생활을 개선하여 다량의 콜레스테롤 및 중성지방의 섭취를 피하고 야채와 생선, 과일등을 통하여 비타민과 섬유질을 충분히 섭취하며, 상황에 따라서는 콜레스테롤을 감소시키는 약을 병행하고 있다.These cholesterol and triglyceride lesions can occur throughout the body and cause cerebral thrombosis, cerebral arteriosclerosis, cerebral hemorrhage, angina pectoris, myocardial infarction, neurosis and hypertension. To prevent and treat such lesions, improve animal-oriented diets characterized by high fat and low fiber, avoid intake of large amounts of cholesterol and triglycerides, and consume enough vitamins and fiber through vegetables, fish and fruits. Some people use drugs that reduce cholesterol.

한국산 겨우살이(Viscum album var.coloratum)는 겨우살이과(Loranthaceae)에 속하는 상록관목으로 다른 나무에 기생하여 자라는 기생식물로써 민간요법에서는 겨우살이의 잎, 줄기를 음건한 후 일정량을 취하여 탕제화하거나 또는 차를 만들어 마시고 있으며, 성인병에 효과가 있는 것으로 알려져 있으나 한국산 겨우살이를 이용한 약제학적인 연구 및 의약품개발은 거의 없는 실정이다.Korean mistletoe (Viscum album var.coloratum) is an evergreen shrub belonging to the group of the mistletoe family (Loranthaceae) .A parasitic plant that grows on other trees and grows in folk medicine. Although it is known to be effective for drinking adult diseases, there is little pharmaceutical research and drug development using Korean mistletoe.

그러나 유럽은 한국산 겨우살이와는 서로 다른 성분을 함유하고 있는 유럽산 겨우살이에 대한 연구를 오랫동안 해오고 있다. 그 동안의 연구결과로 이노시톨, 베타아놀린, 루페올, 비스코톡신, 비스쿠민, 플라보노이드, 다당류, 렉틴계통의 단백질 및 폴리페놀계통의 화합물 등이 확인되었으며, 비스코톡신과 렉틴계통의 단백질은 약간의 독성을 지닌 것으로 알려져 있다. 또한 독일과 스위스에서는 유럽산 겨우살이를 주원료로 사용하여 제조한 항암보조치료제 및 성인병과 관련된 약물들이 정제, 액제 등의 제형으로 개발되어 시판되고 있으며, 최근에는 유럽산 겨우살이에 함유되어 있는 렉틴계통의 단백질을 이용한 항종양 및 에이즈 치료제 개발을 위한 연구들이 매우 활발하게 진행되고 있다.However, Europe has long been studying European mistletoe, which contains different ingredients from Korean mistletoe. As a result of research, inositol, beta-anoline, rufeol, biscotoxin, biscumin, flavonoids, polysaccharides, lectin-based proteins and polyphenol-based compounds have been identified. It is known to have toxicity. Also, in Germany and Switzerland, anti-cancer adjuvants and drugs related to adult diseases, manufactured using European mistletoe as a main ingredient, have been developed and marketed as tablets, liquids, and the like. Research into the development of anti-tumor and AIDS drugs is very active.

본 발명에서는 한국산 겨우살이(Viscum album var.coloratum) 추출물이 콜레스테롤및 중성지방을 억제하며 혈압 강하에 우수한 효능이 있다는 사실을 밝혀내고, 한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기 또는 열매로부터 활성성분을 용매추출하여, 이 추출물이 유효성분으로 함유되어 있어서 콜레스테롤 및 중성지방이 혈관내에 침착하는 것을 억제하며 고혈압의 예방 및 치료에 탁월한 효과를 나타내는 약학조성물과 그 제조방법을 제공하는 데 그 목적이 있다.In the present invention, it was found that the extract of Korean mistletoe (Viscum album var.coloratum) inhibits cholesterol and triglycerides and has an excellent effect on lowering blood pressure, and is active from the leaves, stems or berries of Korean mistletoe (Viscum album var.coloratum). The purpose of the present invention is to provide a pharmaceutical composition and a method for producing the same, which extracts a solvent and suppresses the deposition of cholesterol and triglycerides in blood vessels as an active ingredient and shows an excellent effect on the prevention and treatment of hypertension. have.

본 발명은 한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기 또는 열매로부터의 추출물이 유효성분으로 함유되어 있는 콜레스테롤과 중성지방이 혈관내에 침착하는 것을 억제하며 혈압 강하에 우수한 효과를 나타내는 약학조성물과 그 제조방법을 특징으로 한다.The present invention inhibits the deposition of cholesterol and triglycerides containing extracts from the leaves, stems, or berries of Korean mistletoe (Viscum album var.coloratum) as active ingredients, and shows a pharmaceutical composition showing an excellent effect on lowering blood pressure and The manufacturing method is characterized.

이와 같은 본 발명을 자세하게 설명하면 다음과 같다.The present invention will be described in detail as follows.

본 발명에서 사용한 한국산 겨우살이(Viscum album var.coloratum)는 우리나라 전역에서 야생하는 기생식물로서 참나무, 밤나무, 전나무, 소나무, 사과나무 등의 가지에서 자라는 상록관목이다.Korean mistletoe used in the present invention (Viscum album var.coloratum) is an evergreen shrub that grows on branches such as oak, chestnut, fir, pine, and apple trees as wild plants throughout Korea.

본 발명에서는 한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기 또는 열매로부터 유효성분을 추출하기 위한 추출용매로서 물과 저급알코올 등의 극성용매와 헥산, 에테르 및 클로로포름 등의 비극성용매를 사용할 수 있으며, 추출방법으로는 일반적인 용매추출법과 초음파추출기를 이용한 방법을 사용하였다.In the present invention, a polar solvent such as water and a lower alcohol and a nonpolar solvent such as hexane, ether and chloroform can be used as an extraction solvent for extracting the active ingredient from the leaves, stems or berries of Korean mistletoe (Viscum album var.coloratum). For the extraction method, a general solvent extraction method and an ultrasonic extractor were used.

용매추출법. 겨우살이의 잎과 줄기를 음건한 후 잘게 분쇄한 다음 에틸아세테이트, 클로로포름, 디에칠에테르, n-헥산과 같은 극성이 작거나 비극성 용매를 첨가하여 실온에서 충분하게 침적시켜 탈지하고 여과한다. 잔사에 5∼10배 중량의 수용성 저급알코올을 부가하여 실온에서 추출한다. 또는 시료를 수용성 저급알코올로 추출하여 추출물을 감압농축한 다음 극성이 작거나 비극성 유기용매를 사용하여 탈지화한다. 이렇게 얻은 추출물을 감압농축한 후, 메탄올을 가하여 얻은 메탄올추출물을 감압농축하여 분말이나 일정비의 용매를 함유하고 있는 엑스제로 제조한다.Solvent extraction method. The leaves and stems of mistletoe are dried and pulverized finely, and then sufficiently degreased at room temperature by adding small or nonpolar solvents such as ethyl acetate, chloroform, dieth ether, and n-hexane, and degreased and filtered. A water-soluble lower alcohol of 5 to 10 times the weight is added to the residue, followed by extraction at room temperature. Alternatively, the sample is extracted with a water-soluble lower alcohol, the extract is concentrated under reduced pressure, and then degreased using a small polar or nonpolar organic solvent. The extract thus obtained is concentrated under reduced pressure, and then methanol extract is obtained by adding methanol to concentrate the extract under reduced pressure to prepare a powder or a solvent containing a fixed ratio.

초음파추출기를 이용한 추출법. 용매추출법에서 사용한 동일한 시료를 취하여 충분량의 헥산이 들어 있는 초음파추출기에 넣고 실온에서 추출하여 탈지화한 후 여과한다. 잔사에 5~10배 중량의 수용성 저급알코올을 가하여 실온에서 추출한 다음 그 여액을 감압농축한 후, 메탄올을 부가하여 추출한 메탄올추출물을 감압농축하여 분말이나 엑스제로 제조한다. 또는 시료를 초음파추출기에 넣고 수용성 저급알코올로 추출하여 추출물을 감압농축한 다음 극성이 작거나 비극성 유기용매를 사용하여 탈지화한 후, 감압농축하여 분말이나 엑스제로 제조한다. 이 때 초음파주파수는 10∼50KHz의 범위내에서 조절하며, 초음파추출기를 이용한 추출법은 용매추출법보다 추출시간이 절약되고 추출효율은 높은 편이지만 설비에 대한 비용이 추가되는 단점이 있다.Extraction method using ultrasonic extractor. The same sample used in the solvent extraction method is taken, placed in an ultrasonic extractor containing a sufficient amount of hexane, extracted at room temperature, degreased, and filtered. A water-soluble lower alcohol having a weight of 5 to 10 times was added to the residue, followed by extraction at room temperature. The filtrate was concentrated under reduced pressure, and methanol extract was added thereto to concentrate under reduced pressure to prepare a powder or extract. Alternatively, the sample is placed in an ultrasonic extractor, extracted with a water-soluble lower alcohol, the extract is concentrated under reduced pressure, degreased using a small polar or nonpolar organic solvent, and concentrated under reduced pressure to prepare a powder or extract. At this time, the ultrasonic frequency is controlled within the range of 10 ~ 50KHz, the extraction method using the ultrasonic extractor saves the extraction time and the extraction efficiency is higher than the solvent extraction method, but there is a disadvantage that the cost for the equipment is added.

상기와 같은 방법으로 얻은 한국산 겨우살이(Viscum album var.coloratum)의 엑스나 분말상의 메탄올 추출물을 유효성분으로 하여 전분과 정제수 등의 약제학적 분야에서 사용하는 통상적인 부형제와 함께 제제화하여 정제, 캅셀제, 환제, 과립제 및 액제등의 형태로 제형화 한다.Tablets, capsules, pills and tablets are prepared with conventional excipients used in pharmaceutical fields, such as starch and purified water, using methanol extracts of Korean mistletoe (Viscum album var.coloratum) or powdered methanol obtained as above as an active ingredient. Formulate in the form of granules and liquids.

본 발명은 한국산 겨우살이(Viscum album var.coloratum) 추출물이 유효성분으로 함유되는 약학조성물을 포함하는 바, 유효성분으로 한국산 겨우살이의 추출물은 전체 약제 조성물 중에 0.01∼50% 범위 내에서 함유되는 것이 콜레스테롤 및 중성지방을 억제하고 탁월한 혈압 강하효과를 나타낸다.The present invention comprises a pharmaceutical composition containing the extract of Korean mistletoe (Viscum album var.coloratum) as an active ingredient, the extract of Korean mistletoe as an active ingredient is contained within the range of 0.01 to 50% in the total pharmaceutical composition cholesterol and It suppresses triglycerides and shows an excellent blood pressure lowering effect.

이러한 약제의 용법 용량은 환자의 나이 또는 질병의 정도에 따라 다소 차이는 있지만, 1일 1∼2회 복용하고 1회 복용시 1∼2정(캡슐, 병)을 복용한다.The dosage of these drugs varies somewhat depending on the age of the patient or the severity of the disease, but once or twice a day and 1-2 tablets (capsules, bottles) per dose.

이와 같은 본 발명을 다음의 실시예에 의거 더욱 상세히 설명하겠는 바, 본 발명이 실시예에 의해 한정하는 것은 아니다.Although this invention is demonstrated in more detail based on the following Example, this invention is not limited by an Example.

실시예 1 : 겨우살이 메탄올추출물Example 1 Mistletoe Methanol Extract

한국산 겨우살이(Viscum album var.coloratum)의 잎과 1-2년생된 줄기를 갈변되지 않도록 조심하여 음건한 후 1cm 이하로 잘게 분쇄하여 시료로 사용하였다. 시료 1kg을 취하여 70% 메탄올 5l씩으로 상온에서 6일, 3일, 1일 동안 3회 추출하여 여액을 합한다음 40℃에서 감압농축하였다. 농축물에 n-헥산 500ml를 가하여 잘 흔들어 교반한후(핵산층이 투명할 때까지 반복함) n-핵산층을 제거하고, 메탄올 500ml를 가하여 잘 흔들어 교반한 다음 여과하였다. 3회 반복하여 추출한 메탄올 추출액을 합하여 40℃에서 감압농축하여 263.1g의 분말을 얻었다.The leaves of Korean mistletoe (Viscum album var.coloratum) and 1-2 year old stems were carefully dried to dry and finely pulverized to 1 cm or less and used as samples. 1 kg of the sample was taken and extracted 3 times for 6 days, 3 days and 1 day at room temperature with 5 l of 70% methanol, and the filtrates were combined and concentrated under reduced pressure at 40 ° C. 500 ml of n-hexane was added to the concentrate, shaken well, and the mixture was stirred (repeated until the nucleic acid layer was transparent). The n-nucleic acid layer was removed, and 500 ml of methanol was added to the mixture, followed by stirring. The methanol extracts extracted three times were combined and concentrated under reduced pressure at 40 ° C. to obtain 263.1 g of powder.

실시예 2 : 겨우살이 물추출물Example 2 Mistletoe Water Extract

실시예 1과 동일한 시료 1kg을 취한 다음 정제수를 가하여 충분히 침적시킨 후, 4℃이하에서 일야 방치하여 원심분리한 다음 여과하였다. 동일한 방법으로 2회 반복하여 추출한 여액을 합하여 동결건조방법으로 건조하여 252.3g의 분말을 얻었다.1 kg of the same sample as in Example 1 was taken, and purified water was added thereto, followed by immersion. The mixture was left overnight at 4 ° C. or lower, and then filtered. The filtrate was repeatedly extracted two times in the same manner and combined and dried by lyophilization to obtain 252.3 g of powder.

실시예 3 : 초음파추출기를 이용한 겨우살이 메탄올추출물Example 3 Mistletoe Methanol Extract Using Ultrasonic Extractor

실시예 1과 동일한 시료 1kg을 취하여 초음파추출기에 넣고 70% 메탄올 5l씩으로 실온에서 12시간, 5시간, 5시간 동안 3회 추출한 70% 메탄올 추출액을 합하여 40℃에서 감압농축한 후, 농축물에 n-헥산 500ml를 가하여 잘 흔들어 교반한 후(핵산층이 투명할 때까지 반복함) n-핵산층을 제거하고, 메탄올 500ml를 가하여 잘 흔들어 교반한 다음 여과하였다. 3회 반복하여 추출한 메탄올추출액을 합하여 40℃에서 감압농축하여 268.3g의 분말을 얻었다. 이 때 초음파추출기의 주파수는 25KHz로 조절하였다.1 kg of the same sample as in Example 1 was taken into an ultrasonic extractor, and 70% methanol extract extracted three times for 12 hours, 5 hours, and 5 hours at room temperature with 5 liters of 70% methanol was concentrated under reduced pressure at 40 ° C, and then concentrated to n. 500 ml of hexane was added thereto, shaken well, and the mixture was stirred (it was repeated until the nucleic acid layer was transparent). Then, the n-nucleic acid layer was removed, and 500 ml of methanol was added thereto, shaken well, and filtered. The methanol extracts extracted three times were combined and concentrated under reduced pressure at 40 ° C. to obtain 268.3 g of powder. At this time, the frequency of the ultrasonic extractor was adjusted to 25KHz.

단, 상기 실시예를 통하여 얻어지는 수득율은 20-30%로 겨우살이의 산지에 따라 차이를 나타내었다.However, the yield obtained through the above example was 20-30%, which showed a difference depending on the production of mistletoe.

실시예 4 : 정제의 제조Example 4: Preparation of Tablets

본 발명에 따른 한국산 겨우살이의 메탄올추출물을 전체 함량의 25% 되도록 취한 다음 약제학적 분야에서 사용하는 토통상적인 부형제를 혼합시켜 정제화 하였다.Methanol extract of Korean mistletoe according to the present invention was taken to be 25% of the total content, and then purified by mixing conventional excipients used in the pharmaceutical field.

상기에서 나열된 성분들을 잘게 부숴 혼합한 후, 정제를 제조하였다. 각 정제의 총양은 10Og이다.After crushing and mixing the ingredients listed above, tablets were prepared. The total amount of each tablet is 100 g.

실시예 5 : 캡슐제의 제조Example 5 Preparation of Capsules

본 발명에 따른 한국산 겨우살이의 메탄올 추출물을 전체 함량의 25% 되도록 취하여 약제학적 분야에서 사용하는 통상적인 부형제를 균일하게 혼합한 다음, 혼합물을 과립화하여 일정량씩을 의약 및 식품용 경질 젤라틴 캡슐에 충진시켜 제조하였다.Methanol extract of Korean mistletoe according to the present invention is taken to be 25% of the total content, and uniformly mixed with conventional excipients used in the pharmaceutical field, and then the granules are granulated to fill a predetermined amount into hard gelatin capsules for medicine and food. Prepared.

상기에서 나열된 성분들을 잘게 부숴 혼합하여 분말을 제조한 후, 경질캡슐에 분말 300mg씩을 넣어 캡슐제를 제조하였다.After pulverizing and mixing the ingredients listed above to prepare a powder, the capsule was prepared by putting 300mg of powder in a hard capsule.

실시예 6 : 수액제의 제조Example 6 Preparation of Fluid

본 발명에 따른 메탄올추출물을 전체 함량의 0.075% 되도록 취하여 약제학적 분야에서 사용하는 통상적인 부형제를 혼합하여 균일하게 한 후. 10Og씩 충진하였다.After the methanol extract according to the present invention is taken to be 0.075% of the total content, and mixed with a conventional excipient used in the pharmaceutical field to be uniform. Each 10 g was charged.

실험예 1 : 급성독성 측정Experimental Example 1 Acute Toxicity Measurement

1) 시료조제 : 실시예 1과 실시예 2에서 얻은 물추출물은 물에 녹여 사용하였으며, 메탄올추출물은 0.25g/ml 되도록 식염수에 현탁하여 조제하였다.1) Sample preparation: The water extracts obtained in Examples 1 and 2 were dissolved in water, and methanol extracts were prepared by suspending in saline solution to 0.25g / ml.

2) 실험방법 : ICR계 마우스(평균체중 20.0±2.0g) 10 마리를 한 군으로하여 1)에서 조제한 한국산 겨우살이의 물추출물과 메탄올추출물을 경구투여한 후 14일 동안 마우스의 이상여부를 육안으로 관찰하였다. 표 1에 나타난 바와 같이 한국산 겨우살이의 물추출물과 메탄올추출물에 대한 급성독성(LD50)은 4g/kg 이상으로 독성이 매우 낮은 안전한 물질이다.2) Experimental method: 10 ICR mice (average body weight 20.0 ± 2.0g) in one group were treated with oral administration of water mist and methanol extract of Korean mistletoe prepared in 1). Observed. As shown in Table 1, the acute toxicity (LD 50 ) for water extracts and methanol extracts of Korean mistletoe is a safe substance with a very low toxicity of more than 4 g / kg.

실험예 2 : 혈압 억제효과 측정Experimental Example 2 Measurement of Blood Pressure Inhibitory Effect

1) 시료조제 : 실시예1에서 얻은 겨우살이의 메탄올추출물을 0.25g/ml가 되도록 식염수에 현탁하여 조제하였다.1) Sample preparation: Methanol extract of mistletoe obtained in Example 1 was prepared by suspending in saline solution to 0.25g / ml.

2) 실험방법 : SHR 랫트 4마리를 한군으로 하여 1)에서 조제한 시료를 1일 1회씩 28일 동안 경구투여하였다. 혈압측정은 약물투여 1시간 후에 실시하였으며, 7일 간격으로 측정하였다. 표 2에 나타난 바와 같이 겨우살이 추출물을 투여하지 않은 대조군에서는 경시적인 변화가 없었으나, 겨우살이 메탄올추출물을 투여한 군에서는 유의성 있는 혈압 강하작용을 보여주었다.2) Experimental Method: Four SHR rats were treated as a group, and the sample prepared in 1) was orally administered once a day for 28 days. Blood pressure was measured 1 hour after drug administration and measured at 7 day intervals. As shown in Table 2, there was no change over time in the control group not administered the mistletoe extract, but the group treated with the methanol extract of mistletoe showed a significant blood pressure-lowering effect.

실험예 3 : 콜레스테롤 및 중성지방 억제효과 측정Experimental Example 3 Measurement of Inhibitory Effect of Cholesterol and Triglyceride

1) 시료조제 : 실시예에서 얻은 겨우살이의 수추출물과 메탄올추출물을 0.25g/ml가 되도록 식염수에 현탁하여 조제하였다.1) Sample preparation: The water extract of the mistletoe and the methanol extract obtained in Example were prepared by suspending in saline solution to 0.25g / ml.

2) 실험방법 : IRC계 마우스 10마리를 한 군으로하여 대조군에는 콜레칼시페롤과 콜레스테롤을 각각 3200 IU/kg과 40 mg/kg씩 올리브유에 용해시킨 다음 1일 1회씩 28일 동안 경구투여하여 병변을 유발시킨 후, 1)에서 조제한 한국산 겨우살이의 물추출물과 매탄올추출물을 250mg/kg의 농도로 7일 동안 1일 1회 경구투여하였으며 정상군에는 올리브유만을 투여하였다. 또한 동량의 생리식염수를 대조군과 정상군에 동일한 방법으로 경구투여하였다. 대조군과 정상군을 12시간 동안 절식시킨 후, 우레탄마취하에 복대동맥으로부터 체혈한 혈액을 3000rpm에서 15분 동안 원심분리하여 용혈되지 않은 혈청을 채취한 다음, 효소법에 의해 총콜레스테롤 함량, 총콜레스테롤 중에 함유된 HDL-콜레스테롤 함량(High density 1ipoprotein)을 측정하였으며, 혈청 중의 중성지방인 트리글리세라이드 함량과 칼슘 함량은 각각 측정용 키트를 사용하였다. 그 결과를 다음 표 3에 나타내었다.2) Experimental Method: 10 IRC mice were used as a group. In the control group, cholecalciferol and cholesterol were dissolved in olive oil at 3200 IU / kg and 40 mg / kg, respectively, and then orally administered once a day for 28 days. After inducing the lesions, the water extract and methanol extract of Korean mistletoe prepared in 1) were orally administered once a day for 7 days at a concentration of 250 mg / kg, and the normal group was administered only olive oil. In addition, the same amount of saline was administered orally to the control group and the normal group in the same manner. After fasting the control group and the normal group for 12 hours, unbleeded serum was collected by centrifuging blood from the abdominal aorta for 15 minutes under urethane anesthesia, and then contained in total cholesterol content and total cholesterol by enzymatic method. The HDL-cholesterol content (High density 1 ipoprotein) was measured, and triglyceride content and calcium content, which are triglycerides in serum, were measured for each kit. The results are shown in Table 3 below.

상기에서 본 바와 같이, 본 발명에 의해 얻은 한국산 겨우살이의 잎과 줄기의 용매추출물은 혈압 강하작용이 우수하였고, 콜레스테롤 및 트리글리세라이드 억제효능이 탁월하였다. 특히 한국산 겨우살이의 메탄올추출물은 SHR 랫트의 혈압의 수치를 유의성있는 낮추었으며, 또한 병변을 유도한 쥐의 총콜레스테롤 수치와 중성지방인 트리글리세라이드의 수치를 현저하게 감소시켰고, 반면에 HDL-콜레스테롤 수치를 상당히 높이는 효과가 있음을 알 수 있었다.As seen above, the solvent extracts of the leaves and stems of Korean mistletoe obtained by the present invention had an excellent blood pressure lowering effect and an excellent inhibitory effect on cholesterol and triglycerides. Methanol extract of Korean mistletoe significantly lowered the blood pressure level of SHR rats, and significantly reduced the total cholesterol level and triglyceride, triglyceride, which induced lesions, while reducing HDL-cholesterol level. It was found that the effect is quite high.

Claims (6)

한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기, 열매의 각각 또는 혼합물로부터 추출한 추출물이 유효성분으로 함유되어 고혈압의 예방 및 치료함을 목적으로하는 약학조성물.A pharmaceutical composition for the purpose of preventing and treating hypertension, which contains extracts extracted from each or mixture of leaves, stems and berries of Korean mistletoe (Viscum album var.coloratum). 한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기, 열매의 각각 또는 혼합물로부터 추출한 추출물이 유효성분으로 함유되어 콜레스테롤 및 중성지방이 혈관내 침착을 억제함을 목적으로 하는 약학조성물.A pharmaceutical composition aimed at inhibiting intravascular deposition of cholesterol and triglycerides by containing extracts from the leaves, stems, and fruits of the Korean mistletoe (Viscum album var.coloratum), or mixtures thereof as an active ingredient. 제 1 항, 제 2 항에 있어서, 상기 추출물은 약제조성물중에 0.01 ∼ 50 중량% 함유되어 정제, 캡슐제, 환제, 과립제 또는 액제로 제형화 된 약학조성물.The pharmaceutical composition according to claim 1 or 2, wherein the extract is contained in an amount of 0.01 to 50% by weight in a pharmaceutical composition and is formulated into tablets, capsules, pills, granules, or liquids. 제 1 항, 제 2 항, 제 3 항에 있어서, 사용되는 한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기, 열매의 각각 또는 혼합물로부터 추출물을 얻기 위하여 시료를 지방족탄화수소류, 저급지방산에스데르류, 할로겐화탄화수소류, 에테르류 등의 비극성용매로 탈지화한 후 수용성 유기용매로 추출한 추출액을 감압농축한 다음, 농축물을 물에 용해하는 저급극성유기용매로 추출하는 것을 특징으로 하는 추출방법.The aliphatic hydrocarbons, lower fatty acid esters according to claim 1, 2 and 3, in order to obtain an extract from each or a mixture of leaves, stems and fruits of the Korean mistletoe (Viscum album var.coloratum) used. An extracting method comprising extracting the extract extracted with a water-soluble organic solvent after degreasing with a nonpolar solvent such as oils, halogenated hydrocarbons, ethers, etc., and then extracting the concentrate with a low polar organic solvent dissolved in water. 제 1 항, 제 2 항, 제 3 항에 있어서, 사용되는 한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기, 열매의 각각 또는 혼합물로부터 추출물을 얻기 위하여 시료를 수용성 유기용매로 추출하고 추출액을 감압농축한 다음 농축물을 지방족탄화수소류, 저급지방산에스테르류, 할로겐화탄화수소류, 에테르류 등의 비극성용매로 탈지화한 후, 저급극성 유기용매로 추출하는 것을 특징으로 하는 추출방법.The sample is extracted with a water-soluble organic solvent according to claim 1, 2 or 3, in order to obtain an extract from each of the leaves, stems, and berries of the Korean mistletoe (Viscum album var.coloratum) used. After concentration under reduced pressure, the concentrate is degreased with a nonpolar solvent such as aliphatic hydrocarbons, lower fatty acid esters, halogenated hydrocarbons, ethers, and then extracted with a low polar organic solvent. 제 1 항, 제 2 항, 제 3 항에 있어서, 사용되는 한국산 겨우살이(Viscum album var.coloratum)의 잎, 줄기, 열매의 각각 또는 혼합물로부터 추출물을 얻기 위하여 분쇄한 겨우살이 시료를 초음파추출기를 사용하여 5 ∼ 80℃에서 추출하며, 이 경우 초음.파추출기의 주파수는 10 ∼ 50MHz로 조절하는 것을 특징으로 하는 추출방법.The sample of crushed mistletoe according to claim 1, 2 and 3, to obtain an extract from each of the leaves, stems and berries of the Korean mistletoe (Viscum album var.coloratum) used or a mixture thereof. Extraction at 5 ~ 80 ℃, in this case the ultrasonic wave extractor, characterized in that the extraction method is adjusted to 10 to 50MHz.
KR1019990002629A 1999-01-27 1999-01-27 Pharmaceutical compositions KR20000051921A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990002629A KR20000051921A (en) 1999-01-27 1999-01-27 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990002629A KR20000051921A (en) 1999-01-27 1999-01-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
KR20000051921A true KR20000051921A (en) 2000-08-16

Family

ID=19572559

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990002629A KR20000051921A (en) 1999-01-27 1999-01-27 Pharmaceutical compositions

Country Status (1)

Country Link
KR (1) KR20000051921A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100779565B1 (en) * 2006-05-29 2008-01-28 주식회사 일신웰스 A process of extracting corosolic acid from banaba
KR101325515B1 (en) * 2010-06-15 2013-11-07 주식회사 미슬바이오텍 Korean mistletoe extracts having antiobesity and hepatic steatosis protection activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100779565B1 (en) * 2006-05-29 2008-01-28 주식회사 일신웰스 A process of extracting corosolic acid from banaba
KR101325515B1 (en) * 2010-06-15 2013-11-07 주식회사 미슬바이오텍 Korean mistletoe extracts having antiobesity and hepatic steatosis protection activity

Similar Documents

Publication Publication Date Title
JP2002179586A (en) Lipase inhibitor
ES2613381T3 (en) New extracts of Cynara scolymus, Coffea spp. and Olea Europaea for the treatment of metabolic syndrome
MX2008012230A (en) Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea.
US7767236B2 (en) Plant seed extract composition and process for producing the same
AU2004238122B2 (en) Composition for lowering lipid in body
KR100295366B1 (en) Pathogenic extract with anti-inflammatory activity
KR101317668B1 (en) Pharmaceutical composition for treating and preventing arthritis comprising stauntonia hexaphylla leaf extract
KR100733764B1 (en) Composition comprising the cortex extract of albizzia julibrissin or kuraridinol isolated therefrom for preventing or treating hyperlipidemia
KR100248942B1 (en) Saururus extract with anticancer effect and process for preparation thereof
KR20000051921A (en) Pharmaceutical compositions
WO2008091064A1 (en) Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases
KR100315001B1 (en) Herbal Medicine for the Treatment of Diabetes Mellitus Containing Enteric Bellflower Extract
KR100477957B1 (en) Novel pyrrole derivatives isolated from lycium chinense mill having hepatoprotective activity and composition containing same
KR102165239B1 (en) Hepatoprotective Composition Comprising Abeliophyllum Distichum Extract
KR100679291B1 (en) A composition comprising an extract of ???­??­101 crude drug complex as an effective ingredient for preventing and treating atherosclerosis
KR100416650B1 (en) Extract Polygonatum and composition caontaining the same with hypocholesterolemic and hypoglycemic activities
KR100496622B1 (en) Alcohol fermented food or pharmaceutical composition for prevention of obesity and process for preparation thereof
KR100247568B1 (en) Pharmaceutical compositions for anti-arteriosclerosis
KR20190119020A (en) A composition for anti-inflammation comprising hemistepta lyrata extract
JP2005350432A (en) Prostacyclin formation promoter
JP2006022033A (en) Neovascularization inhibitor
KR20180111479A (en) Anti-obesity functional composition comprising abeliophyllum distchum extract as an active ingredient
KR100569086B1 (en) Acer mono leaf extracts and Phenolic compounds isolated thereof having hepatoprotective activity
KR100373928B1 (en) Plant extract compositions comprising ecdysteroids and iridoids and the use thereof
KR19990080547A (en) Pharmacy Composition

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid